The animal genetic market size was USD 6.44 billion in 2023 and is expected to reach USD 11.47 billion by 2032 and grow at a CAGR of 6.62% over the forecast period of 2024-2032. This report on the animal genetics market provides comprehensive insights into livestock population trends, artificial insemination and embryo transfer adoption rates, and advancements in genomic selection. It analyzes regulatory impacts, funding trends, and key innovations shaping the industry. Additionally, the report highlights success rates in breed improvement, disease resistance data, and sustainability metrics related to genetic advancements. Export and import trends of genetic materials, along with patent filings, are also covered to assess market dynamics. The study further explores the impact of genetic technologies on productivity and efficiency across various livestock species. With a focus on statistical data, emerging trends, and industry developments, this report offers a deep understanding of the market landscape.
The U.S. held the largest market share in the animal genetics market, reaching a market size of USD 1.85 billion in 2023, accounting for 76% of the global market. This dominance is driven by the country’s advanced biotechnology infrastructure, high adoption of artificial insemination (AI) and embryo transfer techniques, and a well-established livestock industry. The presence of key market players, such as Genus Plc, Zoetis Inc., and Neogen Corporation, further strengthens the industry with continuous investments in research and development. Additionally, the rising demand for high-quality livestock breeds, increasing consumption of animal protein, and government support for genetic research in agriculture contribute to the market's expansion. The U.S. also benefits from strict regulatory standards ensuring genetic quality and traceability, making it a global leader in animal genetics.
Drivers
Rising demand for high-quality livestock breeds and genetic advancements drive the animal genetics market growth.
The growing global population and increasing demand for high-quality animal protein have led to a surge in genetically superior livestock breeds. Advances in artificial insemination (AI), embryo transfer, and genome editing technologies have enabled farmers to enhance livestock productivity, disease resistance, and overall genetic quality. The adoption of genomic selection and marker-assisted breeding has further optimized breeding efficiency, ensuring improved meat, milk, and egg production. Additionally, the rising investments in biotechnology and government support for genetic research have accelerated the adoption of animal genetics solutions. As a result, the market is witnessing a rapid transformation in breeding techniques, making genetic advancements a crucial driver for growth in the industry.
Restrain
Ethical concerns and regulatory challenges restrain the growth of the animal genetics market.
The animal genetics industry faces significant challenges due to ethical concerns, regulatory barriers, and stringent government policies. The use of genetic modification and genome editing in livestock raises concerns over animal welfare, biodiversity loss, and potential long-term health risks. Regulatory bodies such as the FDA, USDA, and EFSA impose strict guidelines and approval processes, limiting the commercialization of genetically modified animals. Additionally, public resistance toward genetically engineered animals, particularly in Europe and North America, has created hurdles for market expansion. Compliance with biosafety regulations and intellectual property rights also increases the cost and complexity of genetic research. These factors, combined with the lack of standardized policies across different countries, pose a restraint on the widespread adoption of advanced genetic technologies.
Opportunity
Expansion of precision livestock farming and genetic testing presents new growth opportunities
The integration of precision livestock farming (PLF) technologies with genetic advancements is creating new growth opportunities in the animal genetics market. The adoption of sensor-based monitoring systems, artificial intelligence (AI), and big data analytics is enhancing genetic selection processes, allowing farmers to improve livestock health and productivity. Genetic testing is also gaining traction, enabling early disease detection, parentage verification, and breed optimization. Additionally, the increasing investments in developing low-cost genetic screening tools are making genetic solutions accessible to small and mid-sized farms. Emerging markets, particularly in Asia-Pacific and Latin America, present untapped opportunities as livestock farmers seek high-performance breeds to meet growing protein demand. As technology-driven breeding practices gain momentum, the market is expected to expand significantly in the coming years.
Challenge
High costs of genetic research and breeding technologies pose a major market challenge.
The high cost associated with genetic research, breeding technologies, and biotechnology innovations remains a major challenge for the animal genetics market. The development of genetically enhanced livestock requires significant investments in R&D, specialized infrastructure, and skilled personnel. The cost of advanced reproductive technologies, such as in-vitro fertilization (IVF), embryo transfer, and genomic selection, makes it difficult for small and medium-sized farmers to adopt these solutions. Additionally, high costs of genetic testing, animal health monitoring, and cryopreservation techniques further restrict market accessibility. Financial constraints, particularly in developing countries, limit the widespread adoption of animal genetics solutions. Without cost-effective genetic improvement programs and financial support mechanisms, market penetration in emerging regions remains a challenge, hindering the overall growth potential of the industry.
By Type
The animal genetics market was dominated by the ART segment, which held 52.00% of the total revenue in 2023, owing to the increasing adoption of artificial insemination (AI), embryo transfer (ET), and in-vitro fertilization (IVF). Many companies, such as Genus Plc and Zoetis Inc., have been growing their ART portfolios, and more recently, Zoetis has introduced ART-based solutions for genetic selection. The increasing need for high-yielding and disease-resistant livestock has stimulated the uptake of ART to expedite genetic trait enhancements and help in efficient breeding. This reflects the wider growth of the animal genetics market and the burgeoning interest in precision breeding across it.
By Application
Cattle is anticipated to hold 44% of the market share, making it expected to be the leading animal genetics market segment. Investments in cattle genetic improvement programs have been a result of the growing worldwide needs for premium dairy and meat products. Neogen Corporation and URUS, among other companies, have launched sophisticated genomic testing and AI-based solutions for improving cattle reproduction and enhancing disease resistance, respectively. Combining genomic selection with marker-assisted breeding has further reinforced the segment amid the rising need to improve milk yield, optimize meat quality, and improve the overall productivity of livestock for cattle breeders.
By Distribution Channel
The private distribution channel is anticipated to lead with 68% of the market share during the forecast period, owing to the increased involvement of private genetic service providers and breeding companies as well as biotech firms. Private AI has already been opened by companies like Hendrix Genetics and Topigs Norsvin, bringing AI and genetic solutions to livestock farmers everywhere. Private-sector investments have also been driven by increasing interest in developing tailored breeding programs, genetic testing kits, and working directly with farmers. Such an approach is a key trend driving the growth of the global animal genetics market, facilitating the access to genetic selection and breeding technologies to all scale livestock enterprises.
North America held the largest market share at around 38% in 2023. It is owing to the adoption of advanced breeding technologies, growth in genetic research and investments in North America, and high demand for high-quality livestock breeds in the region. Key players such as Zoetis Inc. and Neogen Corporation are leveraging the forefront of genomic testing solutions for better animal health and productivity, contributing to the dominance of the region. In 2023, Zoetis rolled out new genetic evaluation tools for cattle breeders worldwide to help them make faster selections to improve their breeding programs. Moreover, the increasing use of artificial insemination (AI) and in-vitro fertilization (IVF) on dairy and beef cattle farms has bolstered market expansion. Existing strong livestock farming sectors in the U.S. and Canada also contribute to increased demand for genetic improvement technologies, strengthening North America as a leader in the animal genetics market internationally.
Europe held a significant market share in 2023. It is due to growth in the implementation of genetic research investments, demand for high-quality livestock, and strong government support for the implementation of sustainable animal breeding in the region. Genomic choice, AI, and embryo transfer progress fast at the modernization pace of countries like Germany, France, and the Netherlands. Hendrix Genetics enhanced its animal programs for poultry and swine in 2023 by expanding its genetic improvement programs for breed efficiency and resilience to diseases. Neogen Corporation also introduced new genomics testing solutions for precision breeding in Europe. Rapid market growth due to the region`s approach towards animal productivity enhancement by complying to strict EU animal welfare and sustainability directives are driving the growth of Europe within the global market scenario.
Genus Plc (PIC Genetics, IntelliGen Technologies)
Envigo Corporation (Teklad Diets, Envigo Genetic Models)
Topigs Norsvin (TN70 Sows, Norsvin Landrace)
CRV Holding B.V. (Better Life Health, CRV Fleckvieh)
Groupe Grimaud La Corbiere SA (NOVOGEN Layers, Hubbard Broilers)
Hendrix Genetics BV (Hybrid Layers, Hypor Pigs)
Neogen Corporation (Igenity Genomic Profiles, GeneSeek Genomic Services)
Zoetis, Inc. (Clarifide Genomics, Fostera Vaccines)
URUS (GENEX Genetics, PEAK Genetics)
Animal Genetics, Inc. (Equine Genetic Testing, Canine DNA Testing)
ABS Global (Sexcel Sexed Semen, NuEra Genetics)
STgenetics (UltraPlus Sexed Semen, Chromatin Technology)
VikingGenetics (VikingJersey, VikingHolstein)
Noble Genetics (Noble Sires, Swine Genetic Solutions)
Alta Genetics (Alta Advantage, Alta Bull Search)
WUR Livestock Research (Precision Breeding, Dairy Genomics)
Genex Cooperative (Calf Math, Real World Data Genomics)
Cogent Breeding Ltd. (VisioGen, SexedULTRA Semen)
Semex (Immunity+ Genetics, Semex ai24)
Rocky Mountain Genetics (Bovine IVF Solutions, Custom Embryo Transfer)
In October 2024, SCHOTT Pharma, in partnership with Schreiner MediPharm and Körber Pharma, launched a blister-free syringe packaging solution to cut plastic waste and lower carbon emissions. This eco-friendly design replaces polymer blisters with 100% cardboard mono-material cartons, enhancing sustainability.
In October 2023, SCHOTT AG introduced FIOLAX Pro, an advanced Type I borosilicate glass tubing designed for the pharmaceutical industry. This innovation enhances chemical quality, eliminates heavy metals, and supports complex drug formulations.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD6.44 Billion |
| Market Size by 2032 | USD11.47 Billion |
| CAGR | CAGR of6.62 % From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Assistive Reproduction Technologies, Live Animals, Genomic/Genetic Testing) • By Animal Type (Cattle, Pigs, Sheep & Goats, Companion Animals, Others) • By Distribution Channel (Private, Public) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Genus Plc, Envigo Corporation, Topigs Norsvin, CRV Holding B.V, Groupe Grimaud La Corbiere SA, Hendrix Genetics BV, Neogen Corporation, Zoetis, Inc, URUS, Animal Genetics, Inc., ABS Global, STgenetics, VikingGenetics, Noble Genetics, Alta Genetics, WUR Livestock Research, Genex Cooperative, Cogent Breeding Ltd., Semex, Rocky Mountain Genetics |
Ans: The Animal Genetic Market was valued at USD 6.44 Billion in 2023.
Ans: The expected CAGR of the global Animal Genetic Market during the forecast period is 6.62%
Ans: Private labels will grow rapidly in the Animal Genetic Market from 2024-2032.
Ans: Rising demand for high-quality livestock breeds and genetic advancements drive the animal genetics market growth.
Ans: North America led the Animal Genetic Market in the region with the highest revenue share in 2023.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Livestock Population Statistics
5.2 Regulatory & Compliance Data
5.3 Patent & Innovation Trends.
5.4 Export & Import Trends of Genetic Materials
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Animal Genetic Market Segmentation by Type
7.1 Chapter Overview
7.2 Assistive Reproduction Technologies
7.2.1 Assistive Reproduction Technologies Market Trends Analysis (2020-2032)
7.2.2 Assistive Reproduction Technologies Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Live Animals
7.3.1 Live Animals Market Trends Analysis (2020-2032)
7.3.2 Live Animals Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Genomic/ Genetic Testing
7.4.1 Genomic/ Genetic Testing Market Trends Analysis (2020-2032)
7.4.2 Genomic/ Genetic Testing Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Animal Genetic Market Segmentation By Animal Type
8.1 Chapter Overview
8.2 Cattle
8.2.1 Cattle Market Trend Analysis (2020-2032)
8.2.2 Cattle Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Pigs
8.3.1 Pigs Market Trends Analysis (2020-2032)
8.3.2 Pigs Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Sheep & Goats
8.4.1 Sheep & Goats Market Trends Analysis (2020-2032)
8.4.2 Sheep & Goats Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Companion Animals
8.5.1 Companion Animals Market Trends Analysis (2020-2032)
8.5.2 Companion Animals Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Others
8.5.1 Others Market Trends Analysis (2020-2032)
8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Animal Genetic Market Segmentation By Distribution Channel
9.1 Chapter Overview
9.2 Private
9.2.1 Private Market Trends Analysis (2020-2032)
9.2.2 Private Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Public
9.3.1 Public Market Trends Analysis (2020-2032)
9.3.2 Public Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Animal Genetic Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.4 North America Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.2.5 North America Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.6.2 USA Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.2.6.3 USA Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.7.2 Canada Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.2.7.3 Canada Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.8.2 Mexico Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.2.8.3 Mexico Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Animal Genetic Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.6.2 Poland Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.1.6.3 Poland Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.7.2 Romania Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.1.7.3 Romania Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Animal Genetic Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.4 Western Europe Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.5 Western Europe Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.6.2 Germany Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.6.3 Germany Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.7.2 France Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.7.3 France Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.8.2 UK Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.8.3 UK Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.9.2 Italy Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.9.3 Italy Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.10.2 Spain Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.10.3 Spain Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.13.2 Austria Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.13.3 Austria Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Animal Genetic Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.4 Asia Pacific Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.5 Asia Pacific Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.6.2 China Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.6.3 China Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.7.2 India Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.7.3 India Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.8.2 Japan Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.8.3 Japan Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.9.2 South Korea Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.9.3 South Korea Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.10.2 Vietnam Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.10.3 Vietnam Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.11.2 Singapore Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.11.3 Singapore Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.12.2 Australia Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.12.3 Australia Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Animal Genetic Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.4 Middle East Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.1.5 Middle East Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.6.2 UAE Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.1.6.3 UAE Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Animal Genetic Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.4 Africa Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.2.5 Africa Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Animal Genetic Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.4 Latin America Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.6.5 Latin America Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.6.2 Brazil Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.6.6.3 Brazil Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.7.2 Argentina Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.6.7.3 Argentina Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.8.2 Colombia Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.6.8.3 Colombia Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Animal Genetic Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Animal Genetic Market Estimates and Forecasts, By Animal Type (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Animal Genetic Market Estimates and Forecasts, By Distribution Channel (2020-2032) (USD Billion)
11. Company Profiles
11.1 Genus Plc
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Product/ Services Offered
11.1.4 SWOT Analysis
11.2 Envigo Corporation
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Product/ Services Offered
11.2.4 SWOT Analysis
11.3 Topigs Norsvin
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Product/ Services Offered
11.3.4 SWOT Analysis
11.4 CRV Holding B.V.
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Product/ Services Offered
11.4.4 SWOT Analysis
11.5 Groupe Grimaud La Corbiere SA
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Product/ Services Offered
11.5.4 SWOT Analysis
11.6 Hendrix Genetics BV
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Product/ Services Offered
11.6.4 SWOT Analysis
11.7 Neogen Corporation
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Product/ Services Offered
11.7.4 SWOT Analysis
11.8 Zoetis, Inc.
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Product/ Services Offered
11.8.4 SWOT Analysis
11.9 Animal Genetics, Inc.
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Product/ Services Offered
11.9.4 SWOT Analysis
11.10 ABS Global
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Product/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Type
Assistive Reproduction Technologies
Live Animals
Genomic/ Genetic Testing
By Animal Type
Cattle
Pigs
Sheep & Goats
Companion Animals
Others
By Distribution Channel
Private
Public
Request for Segment Customization as per your Business Requirement: Segment Customization Request
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Nucleic Acid Amplification Testing Market size was USD 7.36 billion in 2023 and is projected to reach USD 20.62 billion by 2032, growing at a 12.16% CAGR.
The Albumin Market Size was valued at USD 6.15 billion in 2023, and is expected to reach USD 10.5 billion by 2032, and grow at a CAGR of 6.1% over the forecast period 2024-2032.
The Bloodstream Infection Testing Market was valued at USD 797.62 Million in 2023 and is expected to reach USD 1213.99 Million by 2032, growing at a CAGR of 4.80% over the forecast period 2024-2032.
The Electric Wheelchair Market was valued at USD 3.66 billion in 2023 and is expected to reach USD 9.82 billion by 2032, growing at a CAGR of 11.50% from 2024 to 2032.
The Healthcare Digital Signage Market Size was USD 6.31 Billion in 2023 & is expected to reach USD 19.78 Bn by 2032 & grow at a CAGR of 13.58% by 2024-2032.
The CAR T-Cell Therapies Market Size was valued USD 4.3 billion in 2023 and is projected to reach USD 35.2 billion by 2032, growing at a CAGR of 26%.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
